Table 3.
envelope, membrane, nucleoprotein, spike
Locus | mutant 1 | mutant 2 | mutant 3 | mutant 4 | mutant 5 | mutant 6 | mutant 7 | mutant 8 | mutant 9 | mutant 10 |
---|---|---|---|---|---|---|---|---|---|---|
T(9)->I | P(71)->L | V(62)->F | L(21)->F | V(58)->F | L(73)->F | S(55)->F | S(68)->F | V(49)->L | V(24)->M | |
30.6% | 0.4% | 0.2% | 0.1% | 0.09% | 0.08 | 0.08% | 0.07% | 0.03% | 0.02% | |
England | Sweden | France | England | |||||||
Europe | ||||||||||
Date | 2020-01-01 | |||||||||
I(82)->T | A(63)->T | Q(19)->E | D(3)->G | A(2)->S | V(70)->L | A(81)->S | F(28)->L | T(30)->I | S(197)->N | |
47.1% | 24.8% | 24.6% | 16% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | |
Senegal | United States | Netherlands | Greece | England | United States | Denmark | Spain | |||
Africa | North America | Europe | North America | Europe | ||||||
Date | 2020-01-01 | 2020-01-19 | 2020-01-01 | 2020-04-27 | 2020-03-15 | |||||
R(203)->M | D(377)->Y | D(63)->G | G(215)->C | G(204)->R | D(3)->L | S(235)->F | Q(9)->L | P(199)->L | A(220)->V | |
62.8% | 63.2% | 62% | 56.8% | 22.3% | 17.2% | 17.3% | 4.3% | 2.5% | 2.5% | |
France | Netherlands | France | England | Canada | Netherlands | England | ||||
Europe | North America | Europe | ||||||||
Date | 2020-01-01 | 2020-04-06 | 2020-01-01 | |||||||
D(614)->G | E(484)->K | L(18)->F | A(222)->V | N(501)->Y | H(655)->Y | K(417)->T | P(681)->H | V(1176)->F | D(138)->Y | |
97.6% | 14% | 16.2% | 14.9% | 13.5% | 12.8% | 9.4% | 7.7% | 10.7% | 10% | |
Russia | England | Australia | England | United States | England | Netherlands | ||||
Europe | Oceania | Europe | North America | Europe | ||||||
Date | 2020-01-01 | 2020-04-07 | 2020-01-01 |